Comparison between adult endocarditis due to beta-hemolytic streptococci (serogroups A, B, C, and G) and

Agnès Lefort1, Olivier Lortholary, Philippe Casassus

  • 1Fédération de Médicine Interne, Maladies Infectieuses et Tropicales, Hôpital Avicenne, Université Paris-Nord, Bobigny, France.

Abstract

Insights

Infective endocarditis (IE) caused by beta-hemolytic streptococci (BHS) affects younger patients with more comorbidities and presents more aggressively than Streptococcus milleri (Sm) IE. BHS IE also shows higher rates of extracardiac complications and mortality.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Microbiology

Background:

  • Limited data exist on infective endocarditis (IE) caused by Streptococcus milleri (Sm) and beta-hemolytic streptococci (BHS).
  • These streptococcal groups share physiologic and pathogenic properties, prompting investigation into similarities in IE presentation.

Purpose of the Study:

  • To compare the clinical characteristics and outcomes of IE caused by Sm and BHS.
  • To identify differences in patient demographics, comorbidities, presentation, and mortality between Sm IE and BHS IE.

Main Methods:

  • Nationwide retrospective study in France (1991-1996).
  • Review of medical and microbiologic charts of adult patients with definite Sm or BHS IE.
  • Multivariate analysis to identify independent risk factors for presentation and death.

Main Results:

  • BHS IE (n=56) occurred in younger patients (median age 59) with more underlying conditions and fewer cardiopathies compared to Sm IE (n=29, median age 66).
  • BHS IE showed more frequent extracardiac complications (55% vs. 39%) and higher mortality (27% vs. 14%).
  • Older age was the only significant risk factor for death in all patients.

Conclusions:

  • Beta-hemolytic streptococci IE presents more aggressively than Streptococcus milleri IE.
  • BHS IE is associated with younger patients, more comorbidities, fewer cardiopathies, and increased complications and mortality.
  • Understanding these differences is crucial for managing streptococcal infective endocarditis.